I've never heard of that product, is it displayed in use by real people? Is it being marketed world wide?

Someone already posted that GERMAN product. It looks like it was made during WW2 with spare parts.

I am also an investor in MYDX and as an investor, even though my position is much worse than someone who bought under current sp, I was able to buy at .01 which was and is the lowest possible sp Incan buyin. There is no way with all the movement and the direction that MYDX is going in that this sp remain forever in subpenny. There is a reason why the sp is where it is and it's not because investors are selling their position. Someone mentioned that the majority of shares held are in investors hands. That says a a lot. And investors are continuing to acquire shares along the way but the market has not begun to be stimulated. As soon as the market is stimulated, we will see the sp go up 10x+ from where it is, no doubt about it.

In response to "That is fascinating.." That's what is so great about CannaDX, individuals are affected differently from another individual. It's the individuals responsibilty to determine what strain feels good or bad and other feelings by use of CannaDX. Strains that are known to the consumer to have negative effects are recorded via Bluetooth MYDX app so when a strain with the same tcp comes up after a sample test, the consumer knows not to smoke it. That's how it works for me. Those are my high standards.

Yes, you have to put in the cannabis sample in the compartment and then CannaDX provides the TCP. That's how it works.

That is false and misleading.

Now that it's being used specifically for medicinal purposes moreso than recreational, it has been developing a more sophisticated following. It's no longer cool to be irresponsible and smoke something that makes you vomit.

I wish I had the great brain Yazbeck has, I wish I knew the science behind all of these great devices, but I admit, I do not. But if I had all the resources Yazbeck has and all the capabilities, I would be doing exactly what he is doing. MYDX is the right thing to do and the right direction to go in to help sustain generations to come and help individuals live a better life if. I, as a consumer of many things do not have the ability to "trust and verify" everything I consume but with all the products that MYDX is developing, licensing, whatever people want to call it, is making all this possible for a lot of people who really need it.

Consumers guess they can trust labels, but I for one know I can trust anything that says "Powered By MYDX" and I know I can trust the results of the CannaDX "trust & verify" process. There is no guessing there. And I believe other consumers would agree.

Quite similarly, when consumers read the nutritional facts on anything they buy that is highly regulated, there is still a margin of error. The nutritional facts are an average of the mass production. Consumers are trusting without verifying that they are only putting 350 calories or 5% saturated fat DV in their bodies. Take frozen dinners for instance. Studies have shown pockets of sodium at harmful levels have been detected in individual frozen dinner packets which reveals the flaw in mass production. Sometimes there are harmful margins of error and consumers trust without verifying. THANKS TO MYDX AND ITS CANNADX PRODUCT THIS DOES NOT HAVE TO BE THE CASE WITH THE CANNABIS INDUSTRY. "Trust & verify" should be available for everything that is mass produced so that each consumer knows what they are putting in their bodies.

Absolutely, CannaDX has proven to function successfully for regular cannabis users for ailment treatments and pain relief as well as letting the consumer know how he/she could feel before smoking the cannabis. It is irresponsible to smoke weed and expect to feel good if you have no idea what you are putting in your body when you smoke it and consumers have the right to know, which is why it is important to "trust & verify"

CannaDX is about a mass of consumers taking individual samples and generating results as opposed to doing one test and assuming all the samples will be accurate. MYDX bridges the gap between dispensary margin of error and consumer consumption.

That's funny, because all the customers who have bought the CannaDX and consume cannabis regularly know the value of CannaDX and how it protects them from flawed mass produced test results. CannaDX tests specific sample, it doesn't give a general breakdown the way dispensaries distribute labeled cannabis products. The consumer has the right to know what affect the cannabis will have on the consumer before the consumer smokes it.

That's the difference between traders and investors. Traders have driven the sp down and investors have been accumulating along the way. It will be the combination of new investor money buying into MYDX and the selling of shares by vendors to new investor money that will drive the sp 10x from where it is and beyond.

That's why most investors stay away from OTC, but individuals like myself and others know what they have in MYDX and NO INVESTORS ARE SELLING 2017!!

OrganaDX will be the answer to that in the detection of harmful pesticides in unregulated cannabis market and of course black market.

MYDX is the only company that offers a product (CannaDX) that allows the consumer to "trust & verify" cannabis to let the consumer know how it could make them feel. Over time, individuals create a dynamic catalogue of various strains reminding them and letting consumers new to the strain how it could make them feel before they put it in their bodies. MYDX is the ONLY COMPANY that is capable of all this.

There are many investors like me that don't seek out OTC investments because they are not designed well for investments. As soon as it goes up 30% in day, traders do their thing and it drives price back down so that it can go back up again and traders will always capitalize on this process. However, MYDX is that rare, less than 1% of all companies in OTC that has the ability to go from where it is now in OTC to trading on the NASDAQ and that is the real dream of an investor picking an OTC company. MYDX is a winner and it is NASDAQ bound. Way too many investor shares aren't being sold for this not to be real. Most investors, like myself whose brokerage doesn't trade subpenny are waiting at .01. When I found out about MYDX in March, the price hadn't peaked the .01 mark, it was at .0086. I waited because my brokerage company doesn't even allow me to place a buy until it is at .01. I had never heard the term "stairway to heaven" until I found MYDX. HUGE BUYS drove the price to .022 and that only happens with investment money. Traders can do all they want to drive the price down but fact remains, INVESTORS ARE NOT SELLING 2017!!

MYDX is the solution to an EXPOSED PROBLEM: unsafe black market weed. Before it was just black market weed, this by itself is not effective for MYDX but now that it's UNREGULATED HARMFUL BLACK MARKET WEED, the only chance consumers have of not being harmed by illegal unregulated weed is the MYDX CannaDX chemical analyzer with proven successful results! Once MYDX becomes PREMIER HOUSEHOLD CANNABIS QUALITY CONTROL backed by consumers and consumer confidence, what other companies will be around to compete? What direct competition does MYDX have? MYDX is the ONLY household cannabis tester that collects user data.

MYDX major reasons why MYDX data is so valuable (followed by reference link):

"However, as MyDx began to analyze the data it accumulated from its testing devices, a much darker picture appeared - you cannot trust what dispensaries sell you."

"Today, if you were to go into any dispensary and ask for "Blue Dream", what do you think you would get? Would you get "Blue Dream"?
According to MyDx data, the answer is unequivocally NO!
Unfortunately, not all Blue Dreams are created equal, unveiling the biggest lie in cannabis. Whereas consumer products outside of cannabis enjoy a higher level of consistency and reliability brought on by stricter enforcement of consumer laws, the same cannot be said about the cannabis industry."

"Fortunately for MyDx users, brand names take a back seat to chemical profiles as MyDx tracks data based on sensory responses, interpreted chemical profiles, and an associated feeling or relief. So while you can't trust the brand name you purchase, you can Trust and Verify® chemical profiles and track how those profiles make you feel using MyDx, which has created another opportunity: green Active Pharmaceuticals Ingredients (gAPI)
"I believe extraction and formulation into a concentrate that can be delivered consistently to help patients find relief for their ailments and symptoms is the next logical step to achieving some level of consistency in the industry," stated Daniel Yazbeck, Chief Executive Officer of MyDx."

http://ir.cdxlife.com/press-releases/detail/59/a-problematic-truth-and-a-solution-in-the-making

MYDX Why gAPI is so valuable (link reference to follow):

"...we are now identifying the specific green Active Pharmaceutical Ingredients (gAPI) that can be derived from cannabis, as well as the dosage of each ingredient that should go into a formulation so it can be tailored for a specific therapy. This information not only supports an active engaged community, but also provides the basis for our Company to partner, sell and supply smart devices and formulations to the various communities we service so they can benefit from tailored cannabis therapies that meet their specific needs."

http://ir.cdxlife.com/press-releases/detail/59/a-problematic-truth-and-a-solution-in-the-making

MYDX is HIPPA compliant, important? You be the judge after considering the following (reference links to follow):

"We are finally getting to the heart of what ailments people are tracking and more importantly, what unique chemicals profiles are helping them find relief," stated Yazbeck. "By mining this HIPPA Compliant Data, we are now identifying the specific green Active Pharmaceutical Ingredients (gAPI) that can be derived from cannabis, as well as the dosage of each ingredient that should go into a formulation so it can be tailored for a specific therapy."

http://ir.cdxlife.com/press-releases/detail/59/a-problematic-truth-and-a-solution-in-the-making

Is HIPPA compliance important (reference link to follow)?

"When dealing with patient ePHI, having a HIPAA compliant provider offers practitioners multiple benefits and peace of mind against impending audits."

http://blog.corespace.com/the-benefits-of-a-hipaa-compliant-provider

Consumers who choose to purchase Black Market cannabis have the right to know what strain they are putting in their bodies and the CannaDX is the only household device that makes it possible. NO ONE should just start taking hits from a bong because it's free. It has proven to be irresponsible and potentially life threatening. Consumers are finally getting educated now that cannabis has proven to have medical applications over a long period of time. Everyone has the right to cure any ailments cannabis can remedy and if they have to go through the black market, they still have the right to "Trust & Verify"

I had made a 24 hr. buyout offer for my shares a while back for $4 a share, but I think you have the right idea at $100pps. All the risk has been taken to prove CannaDX functions the way it is intended, thst is why they can campaign in a huge way in the biggest current cannabis market: CANADA and stimulate a following of consumers utilizing the MYDX trademark "Trust & Verify" from the CannaDX's ability to let you know how a particular strain could make you feel before you smoke it. THERE IS NO OTHER PRODUCT THAT HAS THIS ABILITY. CANNADX HAS ZERO COMPETITION IN AN EXPLODING MARKET. THAT IS WHY VENDORS ARE BECOMING INVESTORS, THAT IS WHY VENDORS ARE NOT SELLING 2017!!!

MYDX IS ROCKING 2017, look out 2018!!!

Weed, any weed that is unregulated AND acquired illegally through form of travel or otherwise can be analyzed by CannaDX to determine whether or not consumer wants to put it in their bodies. If it's unregulated and obtained illegally, consumer is at an even further disadvantage then if it is going by what a labeled purchase would say. Even if the labeled purchase is ok, consumer still has no idea how it will make them feel but with CannaDX, consumers can see how it made others feel and determine if they want to move forward.

That is false as well, when asked, I answered, "as a shareholder, I own more than the product."

MYDX is the solution to an EXPOSED PROBLEM: unsafe black market weed. Before it was just black market weed, this by itself is not effective for MYDX but now that it's UNREGULATED HARMFUL BLACK MARKET WEED, the only chance consumers have of not being harmed by illegal unregulated weed is the MYDX CannaDX chemical analyzer with proven successful results! Once MYDX becomes PREMIER HOUSEHOLD CANNABIS QUALITY CONTROL backed by consumers and consumer confidence, what other companies will be around to compete? What direct competition does MYDX have?

MYDX major reasons why MYDX data is so valuable (followed by reference link):

"However, as MyDx began to analyze the data it accumulated from its testing devices, a much darker picture appeared - you cannot trust what dispensaries sell you."

"Today, if you were to go into any dispensary and ask for "Blue Dream", what do you think you would get? Would you get "Blue Dream"?
According to MyDx data, the answer is unequivocally NO!
Unfortunately, not all Blue Dreams are created equal, unveiling the biggest lie in cannabis. Whereas consumer products outside of cannabis enjoy a higher level of consistency and reliability brought on by stricter enforcement of consumer laws, the same cannot be said about the cannabis industry."

"Fortunately for MyDx users, brand names take a back seat to chemical profiles as MyDx tracks data based on sensory responses, interpreted chemical profiles, and an associated feeling or relief. So while you can't trust the brand name you purchase, you can Trust and Verify® chemical profiles and track how those profiles make you feel using MyDx, which has created another opportunity: green Active Pharmaceuticals Ingredients (gAPI)
"I believe extraction and formulation into a concentrate that can be delivered consistently to help patients find relief for their ailments and symptoms is the next logical step to achieving some level of consistency in the industry," stated Daniel Yazbeck, Chief Executive Officer of MyDx."

http://ir.cdxlife.com/press-releases/detail/59/a-problematic-truth-and-a-solution-in-the-making

MYDX Why gAPI is so valuable (link reference to follow):

"...we are now identifying the specific green Active Pharmaceutical Ingredients (gAPI) that can be derived from cannabis, as well as the dosage of each ingredient that should go into a formulation so it can be tailored for a specific therapy. This information not only supports an active engaged community, but also provides the basis for our Company to partner, sell and supply smart devices and formulations to the various communities we service so they can benefit from tailored cannabis therapies that meet their specific needs."

http://ir.cdxlife.com/press-releases/detail/59/a-problematic-truth-and-a-solution-in-the-making

MYDX is HIPPA compliant, important? You be the judge after considering the following (reference links to follow):

"We are finally getting to the heart of what ailments people are tracking and more importantly, what unique chemicals profiles are helping them find relief," stated Yazbeck. "By mining this HIPPA Compliant Data, we are now identifying the specific green Active Pharmaceutical Ingredients (gAPI) that can be derived from cannabis, as well as the dosage of each ingredient that should go into a formulation so it can be tailored for a specific therapy."

http://ir.cdxlife.com/press-releases/detail/59/a-problematic-truth-and-a-solution-in-the-making

Is HIPPA compliance important (reference link to follow)?

"When dealing with patient ePHI, having a HIPAA compliant provider offers practitioners multiple benefits and peace of mind against impending audits."

http://blog.corespace.com/the-benefits-of-a-hipaa-compliant-provider

I have "nightmare" in the catalogue. When I get a strain recognized as "nightmare" it shows the same TCP and I know not to smoke it. Simple as that. It's fantastic. When it shows up something I've never had with a TCP and a corresponding feeling, even though it could have a different effect on me, at least I'm not going in completely blind and if I like it, I know if a test gives me the same result, I can expect that same feeling.

That's a false statement. It lets me "trust and verify" what I am about to smoke before I put it in my body so I know whether or not to smoke it. It's really exactly what I want from CannaDX.

I had to turn down a weed pro quo today because I didn't have my CannaDX with me. The guy couldn't tell me what strain it was and I wanted to be sure before the deal was done that I didn't get "nightmare".

I definitely will get in when the .01s come in THIS week.

Either way, vendors selling will be giving shares to investors ready to accumulate so, it really makes no difference if vendors sell, it should actually stimulate the market in favor of buyers and since that is yet to be seen, it's hard to argue that vendors are selling.

After all, the shares were given from preferred stock, at the same time the number of common stock shares remained the same. No dillution.

My question isn't answered. And if someone were to say the current state of the sp is due to vendors selling their shares, one would have to say that's pure speculation and misleading. It's a simple equation resulting in sp but the factors are complex. Investors and investment shares being held are in the 100s of millions and no investors are selling 2017.

Where does it show the shares were sold and at what sp?

They're about to undergo another one.

Dr. Ys

Something about overseas transport tanker no pun intended

There are companies currently doing that to stay on NASDAQ, that's not MYDX. Talk about a scam, those companies are currently doing that and 1000 shares is worth less than 1 since the beginning of the year. They've had about 5 reverse splits since January 2017. How many reverse splits has MYDX had since January 2017?

Vendors aren't going to get shares when MYDX is paying cash upfront. Where does it show vendors received shares in lieu of payment?

Low volume trading like hot potatoes, traders are uncertain of the market and are driving the price down. Investors will continue to accumulate shares. NASDAQ investors who don't usually trade on OTC and especially not subpenny are waiting at .01 to buy in 100s of millions of shares.

Big Pharma feeling the Pressure: https://merryjane.com/health/pharmaceutical-companies-are-developing-cannabis-painkillers

Big pharma attempting to minimize future market share loss. This should help drive legislation. Big pharma lobbyists pressuring legislation?

Cannabis Legal in Greece: https://merryjane.com/news/greece-legalizes-medical-marijuana

Trader confidence can get sp soaring, it's looking like hot potatoes are cooling and there isn't much selling and what is selling appears to be in favor of buyers.

100s of millions of shares bought in March by investors. Same shares have been trading same hands like hot potatoes and traders aren't sure what to do, in the mean time they are driving the share price down in low volume due to their uncertainty. Investors are certain of their investment, no selling in 2017 and will continue to grab the hot potatoes from uncertain hands and new investors will buy in volume driving sp 10x from where it is just like in March. MYDX OFFERS THE ONLY HOUSEHOLD CANNABIS ANALYSER THAT COLLECTS USER DATA. MYDX IS A NO-BRAINER FOR INVESTORS.